BioSpace News Archive

Drug Development

Soligenix Announces Publication of Positive Pre-clinical Results for a Novel COVID-19 Vaccine

- Rapid Immune Responses Demonstrated with CoVaccine HT™ Adjuvant in a Prototype Vaccine - Key Attributes including Generation of Neutralizing Antibodies, Th1 Antibody and Cell Mediated Responses Established

July 28, 2020
·
10 min read
Business

Acorda Second Quarter 2020 Update: Webcast/Conference Call Scheduled for August 4, 2020

Acorda Therapeutics, Inc. will host a conference call and webcast in conjunction with its second quarter 2020 update and financial results on Tuesday, August 4 at 4:30 p.m.

July 28, 2020
·
4 min read
Mainstay Medical to Present at the LifeSci Partners Summer Symposium

Mainstay Medical Holdings plc announced that Jason Hannon, Chief Executive Officer, and Matthew Onaitis, Chief Financial Officer, will present a corporate overview at the LifeSci Partners Private Healthcare Company Virtual Summer Symposium on Wednesday, 5 August, 2020.

July 28, 2020
·
1 min read
Pharm Country

Immunome Awarded Department of Defense Contract to Develop Biosynthetic Convalescent Plasma for COVID-19

Up to $13.3M funding to accelerate development and early clinical testing of antibodies derived from large-scale B cell interrogation of COVID-19 “Super-Responders”

July 28, 2020
·
5 min read
Business

Enanta Pharmaceuticals to Host Conference Call on August 4 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Third Quarter Ended June 30, 2020

Enanta Pharmaceuticals, Inc., a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, announced that it plans to report its financial results for its fiscal third quarter ended June 30, 2020 after the U.S.

July 28, 2020
·
2 min read
Business

Seres Therapeutics Reports Second Quarter 2020 Financial Results and Provides Business Updates

– Topline data from SER-109 Phase 3 study in recurrent C. difficile infection expected in August 2020; Potential to be the single pivotal study supporting FDA product registration –.

July 28, 2020
·
14 min read
Business

Schrödinger and Viva Biotech Announce Strategic Collaboration to Generate and Interrogate Structures for Unsolved Targets

Collaboration aims to enable discovery of first-in-class therapeutic candidates

July 28, 2020
·
5 min read
Drug Development

FARXIGA Met All Primary and Secondary Endpoints in Groundbreaking Phase III DAPA-CKD Trial for the Treatment of Patients With Chronic Kidney Disease

FARXIGA significantly reduced the worsening of renal function or risk of death in patients with chronic kidney disease with and without type 2 diabetes

July 28, 2020
·
8 min read
Business

NeoGenomics Reports Revenue of $87 Million in the Second Quarter amid COVID-19 Pandemic

Second-Quarter 2020 Results and Highlights

July 28, 2020
·
16 min read
FDA

Momenta Pharmaceuticals Announces FDA Rare Pediatric Disease Designation for Nipocalimab in HDFN

Momenta Pharmaceuticals, Inc. announced that its novel drug candidate, nipocalimab, has received rare pediatric disease designation from the U.S. Food and Drug Administration for the prevention of hemolytic disease of the fetus and newborn.

July 28, 2020
·
7 min read